- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 311/04 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring
Patent holdings for IPC class C07D 311/04
Total number of patents in this class: 242
10-year publication summary
21
|
15
|
22
|
14
|
14
|
20
|
7
|
10
|
25
|
6
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The General Hospital Corporation | 4733 |
5 |
Exerkine Corporation | 33 |
5 |
Autifony Therapeutics Limited | 48 |
4 |
BIAL - Portela & CA, S.A. | 220 |
4 |
DSM IP Assets B.V. | 5591 |
3 |
Abbvie Inc. | 1800 |
3 |
The Broad Institute, Inc. | 1808 |
3 |
Delivra Inc. | 28 |
3 |
Glaceum, Inc. | 25 |
3 |
Purisys LLC | 24 |
3 |
Merck Sharp & Dohme LLC | 3748 |
3 |
F. Hoffmann-La Roche AG | 7925 |
2 |
The Regents of the University of California | 19918 |
2 |
Boehringer Ingelheim International GmbH | 4650 |
2 |
Janssen Pharmaceutica N.V. | 3392 |
2 |
Centre National de La Recherche Scientifique | 10418 |
2 |
Massachusetts Institute of Technology | 10057 |
2 |
Mayo Foundation for Medical Education and Research | 3206 |
2 |
The Administrators of the Tulane Educational Fund | 391 |
2 |
AMOREPACIFIC Corporation | 2827 |
2 |
Other owners | 185 |